Fmr LLC Sells 294,302 Shares of Maximus, Inc. (NYSE:MMS)

Fmr LLC trimmed its stake in Maximus, Inc. (NYSE:MMSFree Report) by 3.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 8,824,958 shares of the health services provider’s stock after selling 294,302 shares during the quarter. Fmr LLC owned 14.66% of Maximus worth $822,133,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of MMS. Quadrature Capital Ltd purchased a new stake in Maximus during the 1st quarter valued at about $238,000. Price T Rowe Associates Inc. MD increased its position in shares of Maximus by 6.5% during the first quarter. Price T Rowe Associates Inc. MD now owns 38,100 shares of the health services provider’s stock valued at $3,197,000 after acquiring an additional 2,322 shares in the last quarter. Bayesian Capital Management LP purchased a new position in Maximus in the 1st quarter worth approximately $512,000. Tidal Investments LLC lifted its position in Maximus by 238.9% in the 1st quarter. Tidal Investments LLC now owns 12,763 shares of the health services provider’s stock valued at $1,071,000 after acquiring an additional 8,997 shares in the last quarter. Finally, Virtu Financial LLC boosted its stake in Maximus by 16.4% during the 1st quarter. Virtu Financial LLC now owns 3,610 shares of the health services provider’s stock valued at $303,000 after purchasing an additional 508 shares during the last quarter. 97.21% of the stock is owned by hedge funds and other institutional investors.

Maximus Stock Down 0.5 %

Maximus stock opened at $72.50 on Thursday. Maximus, Inc. has a 12 month low of $71.75 and a 12 month high of $93.97. The stock has a fifty day simple moving average of $87.49 and a two-hundred day simple moving average of $87.86. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.59. The firm has a market cap of $4.37 billion, a price-to-earnings ratio of 14.50 and a beta of 0.77.

Maximus Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Saturday, November 30th. Investors of record on Friday, November 15th will be issued a $0.30 dividend. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.20 annualized dividend and a yield of 1.66%. Maximus’s payout ratio is 24.00%.

Insiders Place Their Bets

In other news, insider Michelle F. Link sold 1,363 shares of the business’s stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $92.56, for a total transaction of $126,159.28. Following the completion of the transaction, the insider now directly owns 6,567 shares of the company’s stock, valued at $607,841.52. The trade was a 17.19 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.40% of the stock is owned by insiders.

Maximus Company Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Recommended Stories

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMSFree Report).

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.